ProfileGDS5822 / ILMN_2601330
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 37% 20% 22% 38% 17% 25% 22% 61% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 117.337
GSM1276600PDAC Late Ablation Control 214.920
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 111.822
GSM1276603PDAC Late Ablation 217.938
GSM1276604PDAC Late Ablation 310.917
GSM1303940PDAC Late Ablation_anti-CTLA4 114.125
GSM1303941PDAC Late Ablation_anti-CTLA4 211.622
GSM1303942PDAC Late Ablation_anti-CTLA4 339.561